MAB1719
antibody from Abnova Corporation
Targeting: CD59
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1719 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#MAB1719, RRID:AB_1672386
- Product name
- CD59 monoclonal antibody, clone YUK1
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against native CD59.
- Isotype
- IgG
- Antibody clone number
- YUK1
- Storage
- Store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Complement susceptibility in glutamine deprived breast cancer cells.
p53 regulates cellular resistance to complement lysis through enhanced expression of CD59.
Loss of CD59 expression in breast tumours correlates with poor survival.
CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Expression and function of CD59 on colonic adenocarcinoma cells.
Ellison BS, Zanin MK, Boackle RJ
Cell division 2007 Jul 11;2:20
Cell division 2007 Jul 11;2:20
p53 regulates cellular resistance to complement lysis through enhanced expression of CD59.
Donev RM, Cole DS, Sivasankar B, Hughes TR, Morgan BP
Cancer research 2006 Feb 15;66(4):2451-8
Cancer research 2006 Feb 15;66(4):2451-8
Loss of CD59 expression in breast tumours correlates with poor survival.
Madjd Z, Pinder SE, Paish C, Ellis IO, Carmichael J, Durrant LG
The Journal of pathology 2003 Aug;200(5):633-9
The Journal of pathology 2003 Aug;200(5):633-9
CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S, Caragine T, Cheung NK, Tomlinson S
Cancer research 2000 Jun 1;60(11):3013-8
Cancer research 2000 Jun 1;60(11):3013-8
Expression and function of CD59 on colonic adenocarcinoma cells.
Bjørge L, Vedeler CA, Ulvestad E, Matre R
European journal of immunology 1994 Jul;24(7):1597-603
European journal of immunology 1994 Jul;24(7):1597-603
No comments: Submit comment
No validations: Submit validation data